Here's Why AbCellera Biologics Stock Gained 10.6% Last Month
Shares of AbCellera Biologics (NASDAQ: ABCL) climbed 10.6% in June, according to data from S&P Global Market Intelligence. The biotech company published its second-quarter earnings release on Aug. 12 and held a conference call to discuss its results and outlook, and the market liked what it heard.
Source Fool.com